The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Live from the floor at the 2026 RIU Explorers’ Conference in sunny Fremantle, WA, HotCopper spoke with Gorilla Gold Mines (ASX:GG8) CEO Charles Hughes to discuss the company’s trajectory through this auspicious Year of the Horse.

Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.

Not only did our Senior Markets Reporter bully (me) Charles into predicting the gold price, but investors can watch to hear what the company’s plans for 2026 look like, as well as previous wins across the last year.

Gold bug traders probably know Gorilla Gold well –but for the uninitiated, tune in to get an idea of what it is about GG8 that gets people watching.

Join the discussion: See what’s trending right now on HotCopper, Australia’s largest stock forum, and be part of the conversations that move the markets.

The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.

gg8 by the numbers
More From The Market Online
US flag

Dateline Resources pops +40% on Trump gov’t move to greenlight REE and gold mining

An injunction on ASX-listed Dateline Resources’ (ASX:DTR) California-based Colosseum REE and gold project appears set to be lifted after
The ASX Today feature image with a blue Australia silhouette (STOCK) beside The Market Link column branding.

ASX Today: XJO has a good day ahead of RBA rate call; AU bond sell-off continues

While we’re set to get the RBA’s next rate decision tomorrow – which all big bank analysts think is going to be a
Aussie cash

Northern Star jumps +7% on confirmed takeover rumour from Gold Fields Ltd

ASX-listed Northern Star Resources (ASX:NST) has confirmed reports in Bloomberg that it’s received a 100% takeover offer from a

AFT Pharmaceuticals opens Japan opportunity for Maxigesic IV

AFT Pharmaceuticals (ASX: AFP) has secured an exclusive development, licensing and supply agreement for its Maxigesic® IV (also known as Combogesic® IV)